X-FASNet:用于阿尔茨海默病认知衰退评估的跨度特征意识与自我注意网络
Wenhui Chen1, Shunwu Xu1, Yiran Peng1,2
1Key Laboratory of Nondestructive Testing, Fujian Polytechnic Normal University, Fuzhou, China.
Frontiers in neurology
|August 28, 2025
概括
早期发现阿尔茨海默病至关重要. 一个高效的跨尺度特征感知自我注意网络 (X-FASNet) 通过整合多尺度特征以更好地识别解剖变化来改善早期神经退化.
科学领域:
- 神经科学
- 人工智能
- 医学成像分析
背景情况:
- 早期诊断阿尔茨海默病对于及时治疗至关重要.
- 在AD的认知衰退需要先进的计算方法来检测早期微妙的神经解剖学变化.
- 现有的多尺度神经网络在跨尺度特征集成方面扎,限制了它们识别早期神经退行性标记的能力.
研究的目的:
- 推出一个高效的跨度特征意识自我注意网络 (X-FASNet),以改善神经退行症的早期诊断.
- 增强神经解剖学细微变异和病理模式的检测.
- 克服当前神经网络在神经成像分析的跨度特征集成方面的局限性.
主要方法:
- 开发了一种新型的高效跨度特征感知自我注意网络 (X-FASNet),利用系统的层次表示学习.
- 实施双路径多尺度特征提取方法以识别歧视性神经解剖学模式.
- 整合了一个跨度特征自觉注意模块,以改善跨度信息交换和捕获远程依赖.
主要成果:
- 在DPC-SF数据集上,X-FASNet获得了93.7%的准确性和0.973的F1得分.
- 拟议的网络显著优于CONVADD (精度为10.8%) 和EfficientB2等现有方法.
- 多个神经成像数据集的实验证实了X-FASNet在神经退行评估中的有效性.
结论:
- X-FASNet提供了一个强大的计算框架,用于早期评估神经退行.
- 该网络在检测早期阿尔茨海默病诊断中至关重要的细微解剖变异方面表现出卓越的能力.
- 使用X-FASNet的增强病理模式识别可以显著帮助阿尔茨海默病的临床决策.
更多相关视频
08:43Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
Published on: August 7, 2017
8.0K
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.7K
相关概念视频
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260